Application of a scoring system based on immune gene pairs in predicting the effect of immunotherapy in patients with non-small cell lung cancer
A non-small cell lung cancer and gene pairing technology, applied in the field of biomedicine, can solve the problems of low clinical application value, small sample overfitting, lack of validation, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Example 1. Application of IRGPI in predicting the efficacy and prognosis of anti-PD-1 immunotherapy for non-small cell lung cancer 1. Research subjects
[0047] The information of the research subjects is shown in Table 1, which are divided into three cohorts, namely the GSE93157 cohort, the GSE136961 cohort and the CICAMS cohort.
[0048] Table 1. Information on research objects
[0049]
[0050]
[0051] Among them, the GSE93157 cohort mainly included patients with advanced thoracic malignancies who were treated with anti-PD-1 antibodies at Hebron Valley Hospital and Barcelona University Hospital in Spain. Inclusion criteria were: 1) patients with clinically diagnosed locally advanced or locally advanced non-small cell lung cancer; 2) received immunotherapy for the first time, with no limit on the number of lines of treatment; 3) both in Hebron Valley Hospital and Barcelona in Spain before immunotherapy Lung cancer surgery is performed at the University Hospita...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com